OMedLive

CME Presentations

Breast Cancer: HER2 Positive


Presentations

  • CME
    1.0

    Updates on HER2 Positive Breast Cancer Management

    Speakers:Harold J. Burstein, MD, PhD, Medical Oncologist
    Eric Winer, MD, Director, Breast Oncology Center

    Duration: 60 minutes

    Presented on: June 10, 2016


Speakers

  • Harold J. Burstein, MD, PhD

    Harold J. Burstein, MD, PhD

    Harold J. Burstein, MD, PhD

    Medical Oncologist

    Harold J. Burstein, M.D., Ph.D. is an Associate Professor of Medicine at Harvard Medical School, and a medical oncologist at Dana-Farber Cancer Institute and Brigham & Women's Hospital. Dr. Burstein attended Harvard College, and earned his MD at Harvard Medical School where he also earned a PhD in immunology. He additionally has a master's degree in history of science from Harvard. He trained in internal medicine at Massachusetts General Hospital and in medical oncology at Dana-Farber.

    His clinical research interests include novel treatments for early- and advanced-stage breast cancer, and studies of quality of life and health behavior among women with breast cancer. Dr. Burstein has written widely on breast cancer in both traditional medical journals and on the web. Representative publications can be found in the New England Journal of Medicine, the Journal of Clinical Oncology, and other leading medical journals. He serves on international breast cancer committees including the NCCN Breast Cancer Panel, The St. Gallen Breast Cancer Panel, and the Alliance Breast Cancer Committee, and chairs the ASCO guidelines on endocrine therapy for breast cancer. Dr. Burstein an Associate Editor for Cancer Education at the Journal of Clinical Oncology.
  • Eric Winer, MD

    Eric Winer, MD

    Eric Winer, MD

    Director, Breast Oncology Center

    Eric P. Winer, MD, is professor of medicine at Harvard Medical School, chief, Division of Women's Cancers, the Thompson Chair in Breast Cancer Research, and chief clinical strategy officer at Dana-Farber Cancer Institute. He is the leader of the Dana-Farber/Harvard Cancer Center Breast Program, and is the principal investigator/director of the Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer. Dr Winer has designed and led phase I, II, and III clinical trials, and collaborates closely with psychosocial researchers, health services researchers, and basic and translational scientists. His group at Dana-Farber conducts a broad array of breast cancer research with the goal of extending the lives of individuals with breast cancer, and minimizing suffering and morbidity from the disease.

CME Information

Updates on HER2 Positive Breast Cancer Management

 

ACKNOWLEDGEMENT This educational activity is supported by an educational grant from Genentech.

TUITION Complimentary

ACCREDITATION STATEMENT The activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine and PlatformQ Health Education, LLC. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENTS Live Internet Activity Albert Einstein College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Enduring Material Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

OTHER CREDITS American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. American Academy of Physician Assistants (AAPA) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Physician assistants may receive a maximum of 2.0 hour of Category 1 credit for completing this program

DATE OF RELEASE/EXPIRATION Live Activity Friday, June 10, 2016 from 1:00PM EST- 2:00PM EST Enduring Material The enduring material will be available from June 10, 2016 to June 10, 2017.

LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to:

Summarize the efficacy and safety of new and emerging treatment approaches for HER2 positive breast cancer in the neoadjuvant, adjuvant and metastatic settings
Evaluate therapeutic challenges associated with HER2-targeted treatment, including resistance, toxicity and optimal duration of treatment
 

TARGET AUDIENCE Oncologists, hematologist-oncologists, radiation oncologists, breast surgeons, oncology nurse practitioners, pharmacists, and other healthcare professionals who treat patients with breast cancer

ESTIMATED TIME TO COMPLETE This activity consists of one session, which should take approximately 1 hour to complete.

METHOD OF PARTICIPATION There are no fees to participate in this activity. To participate in the activity, go to www.omedlive.com. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the post-test and activity evaluation. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the post-test.

HARDWARE/SOFTWARE REQUIREMENTS Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

FACULTY DISCLOSURE The "Conflict of Interest Disclosure Policy" of Albert Einstein College of Medicine requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest, with regard to their contribution to the activity, will not be permitted to present.

The Albert Einstein College of Medicine also requires that faculty participating in any CME activity and anyone in a position to influence content disclose to the audience when discussing any unlabeled or investigational use of any commercial product, or device, not yet approved for use in the United States.

Presenters Disclosures
Harold Burstein, MD, PhD

To be posted prior to the live internet activity

Eric Winer, MD

To be posted prior to the live internet activity

Providers Disclosures
Einstein-Montefiore Center for Continuing Medical Education The Center for Continuing Medical Education (CCME) staff at Albert Einstein College of Medicine has no disclosures to report relevant to this activity.
Peer Reviewer Disclosures
Jesus Anampa Mesias, MD To be posted prior to the live internet activity
PlatformQ Health Education, LLC Disclosures
Hamsa Jaganathan, Medical Director To be posted prior to the live internet activity
Randi O’Hara, Senior Program Manager Has nothing to disclose relevant to this activity.
 

DISCLAIMERS (if applicable): The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material.

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by Albert Einstein College of Medicine, OMedLive, PlatformQ Health Education, LLC or the program grantor. Reasonable efforts have been made to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

CONTACT INFORMATION Accreditation Support: Please send all inquiries to: Montefiore Medical Center, CCME, 3301 Bainbridge Avenue, Bronx, New York 10467, or via phone at (718) 920-6674, or via fax to (718) 798-2336, or via email to cme@montefiore.org.

Technical Support: For any technical issues or issues with your CME Certificate, please contact OMedLive at 877-394-1306 or at Support@OMedLive.com